
Multiple Myeloma Evolution: Cereblon E3 Ligase Modulators as Next-Generation Therapy in Relapsed/Refractory Disease
Wednesday, September 30, 2026
1:00 p.m. – 2:00 p.m. ET
Please note this TeleECHO program is 1:00 p.m. Eastern, 12:00 p.m. Central, 11:00 a.m. Mountain and 10:00 a.m. Pacific.







